fluoxetine has been researched along with Bladder Cancer in 3 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fluoxetine was also found to inactivate the phosphorylation of STAT3 (Tyr705) and NF-κB (Ser536) and suppress the nuclear translocation of NF-κB." | 5.91 | Fluoxetine inactivates STAT3/NF-κB signaling and promotes sensitivity to cisplatin in bladder cancer. ( Chiang, CH; Hsu, FT; Tan, ZL; Yang, CJ; Yang, JD, 2023) |
| "Fluoxetine was also found to inactivate the phosphorylation of STAT3 (Tyr705) and NF-κB (Ser536) and suppress the nuclear translocation of NF-κB." | 1.91 | Fluoxetine inactivates STAT3/NF-κB signaling and promotes sensitivity to cisplatin in bladder cancer. ( Chiang, CH; Hsu, FT; Tan, ZL; Yang, CJ; Yang, JD, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, CJ | 1 |
| Tan, ZL | 1 |
| Yang, JD | 1 |
| Hsu, FT | 1 |
| Chiang, CH | 1 |
| Lin, YM | 1 |
| Yu, BC | 1 |
| Chiu, WT | 1 |
| Sun, HY | 1 |
| Chien, YC | 1 |
| Su, HC | 1 |
| Yen, SY | 1 |
| Lai, HW | 1 |
| Bai, CH | 1 |
| Young, KC | 1 |
| Tsao, CW | 1 |
| Tang, KY | 1 |
| Lu, T | 1 |
| Chang, CH | 1 |
| Lo, YK | 1 |
| Cheng, JS | 1 |
| Wang, JL | 1 |
| Chang, HT | 1 |
| Jan, CR | 1 |
3 other studies available for fluoxetine and Bladder Cancer
| Article | Year |
|---|---|
Fluoxetine inactivates STAT3/NF-κB signaling and promotes sensitivity to cisplatin in bladder cancer.
Topics: Animals; Apoptosis; Caspases; Cell Line, Tumor; Cisplatin; Fluoxetine; Mice; NF-kappa B; STAT3 Trans | 2023 |
Fluoxetine regulates cell growth inhibition of interferon-α.
Topics: Antiviral Agents; Blotting, Western; Cell Proliferation; Flow Cytometry; Fluorescent Antibody Techni | 2016 |
Effect of fluoxetine on intracellular Ca2+ levels in bladder female transitional carcinoma (BFTC) cells.
Topics: Calcium; Carcinoma, Transitional Cell; Cell Line; Estrenes; Female; Fluoxetine; Humans; Indicators a | 2001 |